Industry news

Russia approved list of 96 bio-targets to develop the medicinal products analogues

GMP News

On June 8, 2016, the Russian Ministry of Justice registered the joint Order of the Ministry of Industry and Trade and the Ministry of Health of Russia “On Approval of the List of Bio-Targets for Developing the Analogues of Innovative Medicinal Products With Similar and Improved Pharmacotherapeutic Effect.” The list includes 96 items.

Market share of Russian-made cancer drugs reached 75-80% within three years

GMP News

The share of Russian-made drugs for treatment and prevention of oncological diseases in the domestic market reached 75-80% in three years. This was announced by Mikhail Davydov, the part-time oncologist of the Ministry of Health of the Russian Federation and Director of N.N. Blokhin Russian Cancer Research Center.

Trump White House at work on executive order tackling drug prices: report

Eric Sagonowsky / FiercePharma

If President Donald Trump can’t count on Congress to pass legislation targeting high drug prices, his administration may have to go it alone. The White House is working on an executive order on the issue, according to BioCentury, with eyes on value-based contracting for executive agencies.

EU, U.S. and Japanese regulators join forces on antibiotic trials

Ben Adams / Fierce Biotech

The three drug regulators from Europe, the U.S. and Japan have come together in a data share program aimed at boosting antibiotic development. Long held as one of the most overlooked but potentially devastating areas of development, antibiotic resistance and a lack of new meds in this area have increasingly become a major concern for governments.

Facebook, Google and Twitter techs to push digital media at Cannes pharma ad fest

Beth Snyder Bulik / FiercePharmaMarketing

Digital media giants will take to the south of France once again this weekend to woo pharma and healthcare marketers. Facebook, Google and Twitter will present and meet up with marketers and ad agencies at the Cannes Lions Health two-day ad festival with an eye toward accelerating the shift from traditional TV and print media to digital and social channels.

Want to earn more, pharma reps? Go large, get on the road or jump to biotech

Tracy Stanton / Fierce Pharma

The place to be in drug sales is biotech. Yet another year’s worth of salary and bonus data show that biotech reps are outearning every category in the medical sales field save health IT.

Like? Pharma and OTC brands get the Facebook treatment at first of many confabs

Beth Snyder Bulik / FiercePharmaMarketing

Pharma finally has a seat at the table with other industries in digital marketing. The Facebook table, that is. This week, the social network convened its first health summit, a practice it already employs widely in other industries, in Facebook's ongoing gambit to secure drug marketers' trust—and advertising budgets. 

Percentage of Russian-made drugs in healthcare procurement reached 72.4% in Q1

GMP News

According to the hospital audit of Russian pharmaceutical market conducted by DSM Group, 203.9 million packages of medicinal products worth 45.9 billion rubles were purchased for healthcare facilities in Q1 2017.

List of manufacturers participating in the Russian project on drug labelling

GMP News

The experiment on labeling certain medicinal products for human use with control (identification) marks and monitor their circulation is conducted in the Russian Federation from February 1 to December 31, 2017.

Russia elaborates a strategy for microorganisms resistance to medicinal products

GMP News

The Ministry of Health of the Russian Federation elaborated a draft law “On the Approval of the Strategy for Preventing and Overcoming the Resistance of Microorganisms and Noxious Organisms of Plants to Medicinal Products, Chemicals and Biologics for the Period until 2030 and Beyond.”